AriBioLab Co.,Ltd. (KOSDAQ:261780)
South Korea · Delayed Price · Currency is KRW 3,900.00
+240.00 (6.56%)
At close: Oct 16, 2026
AriBioLab Market Cap
AriBioLab has a market cap or net worth of 109.25 billion as of October 16, 2026. It is the 27,194th most valuable company in the world and the 1,250th biggest in South Korea. Its market cap has increased by 58.55% in one year.
Market Cap
109.25B
Enterprise Value
99.80B
Revenue
173.16M
Global Rank
Country Rank
#1,250 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since October 22, 2021, AriBioLab's market cap has decreased from 343.58B to 109.25B, a decrease of -68.20%. That is a compound annual growth rate of -20.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 109.25B | 43.96% |
| Dec 30, 2025 | 75.89B | -7.54% |
| Dec 30, 2024 | 82.08B | -45.65% |
| Dec 28, 2023 | 151.04B | 14.64% |
| Dec 29, 2022 | 131.75B | -55.09% |
| Dec 30, 2021 | 293.36B | -14.62% |
| Oct 22, 2021 | 343.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kanaph Therapeutics | 125.03B |
| TiumBio | 118.20B |
| ViGenCell | 104.75B |
| Y-Biologics | 102.96B |
| Cell Biotech | 101.77B |
| Prestige Biologics | 100.61B |
| CORESTEMCHEMON | 84.33B |
| BIO-FD&C | 83.04B |